# MFSD2B

## Overview
The MFSD2B gene encodes the MFSD2 lysolipid transporter B, a transmembrane protein that is part of the major facilitator superfamily (MFS) of transporters. This protein is primarily involved in the transport of sphingosine-1-phosphate (S1P), a critical signaling lipid, across cell membranes, particularly in erythroid cells. MFSD2B plays a vital role in maintaining plasma S1P levels, which are essential for vascular integrity, blood vessel development, and lymphocyte trafficking (Kobayashi2018MFSD2B; Le2021Mfsd2b). The protein's structure is characterized by twelve transmembrane regions, which facilitate its function as a transporter. It is predominantly expressed in bone marrow, where it contributes to the regulation of S1P levels in the bloodstream (Kobayashi2018MFSD2B). The activity of MFSD2B is crucial for various physiological processes, and its dysfunction has been linked to several health conditions, including thrombotic disorders and cardiac remodeling (Duse2024Deficiency; Chandrakanthan2021Deletion).

## Structure
The MFSD2B protein is a member of the major facilitator superfamily (MFS) of transporters, characterized by its role as a sphingosine 1-phosphate (S1P) transporter in erythroid cells. The protein consists of 494 amino acid residues and is predicted to have twelve transmembrane regions, which are typical of MFS transporters and form a channel for substrate transport (Kobayashi2018MFSD2B). Molecular modeling, based on crystal structures of bacterial MFS transporters, has identified key residues such as Lys413 and Asp85, which are crucial for S1P transport activity. These residues are located near the membrane lipids, suggesting their involvement in S1P binding or recognition (Kobayashi2018MFSD2B).

The primary structure of MFSD2B shows a high degree of similarity between human and mouse versions, with 83% identity and 96% similarity, and both are detected as a band of approximately 43 kDa in size (Kobayashi2018MFSD2B). The tertiary structure involves the folding of these transmembrane helices, although specific details on the quaternary structure are not provided. The protein's activity is partially inhibited by glyburide, indicating potential regulatory mechanisms affecting its function (Kobayashi2018MFSD2B).

## Function
The MFSD2B gene encodes a protein that functions as a transporter for sphingosine-1-phosphate (S1P), a critical signaling molecule involved in various physiological processes. In healthy human cells, MFSD2B is primarily active in erythroid cells, where it facilitates the export of S1P, contributing significantly to the regulation of S1P levels in the bloodstream (Kobayashi2018MFSD2B). This protein is a member of the major facilitator superfamily (MFS) of transporters and is expressed predominantly in bone marrow, where erythrocytes are produced (Kobayashi2018MFSD2B).

MFSD2B plays a crucial role in maintaining plasma S1P levels, which are essential for blood vessel development, function, and lymphocyte trafficking (Le2021Mfsd2b). The transporter is responsible for exporting approximately 50% of plasma S1P, which is vital for maintaining vascular integrity and homeostasis (Le2021Mfsd2b). The activity of MFSD2B is not dependent on sodium or potassium ion gradients, and specific residues such as Asp85 and Lys413 are important for its S1P export function (Kobayashi2018MFSD2B). Through its role in S1P transport, MFSD2B contributes to the regulation of lipid signaling and cellular homeostasis in healthy human cells.

## Clinical Significance
Mutations or alterations in the expression of the MFSD2B gene have been implicated in various health conditions, particularly those related to platelet function and cardiac remodeling. In platelets, MFSD2B is crucial for the export of sphingosine-1-phosphate (S1P), a lipid involved in thrombosis. Deletion of MFSD2B in mice leads to impaired platelet morphology and function, resulting in reduced thrombus formation. This suggests that MFSD2B plays a significant role in thrombotic disorders, and its dysfunction could potentially reduce the risk of conditions like deep venous thrombosis (Chandrakanthan2021Deletion).

In the context of cardiac health, MFSD2B deficiency has been shown to protect against hypertension-induced cardiac remodeling. This protection is linked to the suppression of L-type calcium channel activity, which is mediated by increased S1P levels and subsequent activation of protein phosphatase 2A (PP2A). The altered calcium homeostasis due to MFSD2B deficiency helps preserve cardiac function under hypertensive stress, suggesting a potential therapeutic target for conditions like heart failure and hypertension (Duse2024Deficiency).

These findings highlight the clinical significance of MFSD2B in both thrombotic and cardiac conditions, indicating that alterations in its expression or function could have protective or detrimental effects depending on the context.


## References


[1. (Duse2024Deficiency) Dragos Andrei Duse, Nathalie Hannelore Schröder, Tanu Srivastava, Marcel Benkhoff, Jens Vogt, Melissa Kim Nowak, Florian Funk, Nina Semleit, Philipp Wollnitzke, Ralf Erkens, Sebastian Kötter, Sven Günther Meuth, Petra Keul, Webster Santos, Amin Polzin, Malte Kelm, Martina Krüger, Joachim Schmitt, and Bodo Levkau. Deficiency of the sphingosine-1-phosphate (s1p) transporter mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the l-type-ca2+ channel. Basic Research in Cardiology, August 2024. URL: http://dx.doi.org/10.1007/s00395-024-01073-x, doi:10.1007/s00395-024-01073-x. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00395-024-01073-x)

[2. (Kobayashi2018MFSD2B) Naoki Kobayashi, Shoko Kawasaki-Nishi, Masato Otsuka, Yu Hisano, Akihito Yamaguchi, and Tsuyoshi Nishi. Mfsd2b is a sphingosine 1-phosphate transporter in erythroid cells. Scientific Reports, March 2018. URL: http://dx.doi.org/10.1038/s41598-018-23300-x, doi:10.1038/s41598-018-23300-x. This article has 66 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-23300-x)

3. (Le2021Mfsd2b) Mfsd2b and Spns2 are essential for maintenance of blood vessels during development and protection of anaphylaxis. This article has 0 citations.

[4. (Chandrakanthan2021Deletion) Madhuvanthi Chandrakanthan, Toan Quoc Nguyen, Zafrul Hasan, Sneha Muralidharan, Thiet Minh Vu, Aaron Wei Liang Li, Uyen Thanh Nha Le, Hoa Thi Thuy Ha, Sang-Ha Baik, Sock Hwee Tan, Juat Chin Foo, Markus R. Wenk, Amaury Cazenave-Gassiot, Federico Torta, Wei Yi Ong, Mark Yan Yee Chan, and Long N. Nguyen. Deletion of mfsd2b impairs thrombotic functions of platelets. Nature Communications, April 2021. URL: http://dx.doi.org/10.1038/s41467-021-22642-x, doi:10.1038/s41467-021-22642-x. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-22642-x)